In this interview with Milaan Shah, MD, the expert consensus panel reviewing deucravacitinib’s safety and efficacy for psoriasis is discussed.
Milaan Shah, MD
Advertisement
Articles by Milaan Shah, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Brensocatib Patient Selection Evolves 1 Year After FDA Approval
2
CKM Syndrome, Artery Damage Prevalence Higher in Young Adults than Previously Believed
3
ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD
4
Why Mentorship Matters Most for Dermatology Trainees
5